Target intelligence / Profile preview

Shigella flexneri 6 O-antigen polysaccharide

Molecular classification
Polysaccharide, Other
01

Overview

The Shigella flexneri 6 O-antigen polysaccharide is a component of the lipopolysaccharide (LPS) outer membrane of Shigella flexneri serotype 6 bacteria, differing from the common backbone shared by most other S. flexneri serotypes (e.g., serotype Y). It consists of repeating oligosaccharide units that contribute to serotype specificity through structural variations, including potential phage-mediated modifications like glucosylation or O-acetylation, though specific modifications for serotype 6 are less detailed compared to others. This polysaccharide is recognized by antibodies such as those in serological assays and plays a key role in eliciting host immune responses, making it relevant for vaccine development targeting Shigella infections. Structural studies note its distinction from the basic tetrasaccharide repeat [→3)-β-D-GlcpNAc-(1→2)-α-L-RhapII-(1→2)-α-L-RhapIII-(1→3)-α-L-RhapI-(1→ of serotype Y, with serotype 6 sharing some group 1 antigen features but having a unique O-antigen profile. Conformational flexibility, potentially helical, aids in antibody binding and immune evasion.

Other names
S. flexneri serotype 6 O-antigenShigella flexneri 6 O-polysaccharide
02

Biological functions

Host immune response inductionBacterial outer membrane protectionSerotype specificity
03

Disease associations

Infection

Beyond the preview

Go deeper on Shigella flexneri 6 O-antigen polysaccharide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shigella flexneri 6 O-antigen polysaccharide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call